Dr Lal Path Labs Part 3 | Stock Review & Rating | Governance & Summary
Published on 25 October 2019|
3 Part Analysis & rating of Dr Lal PathLabs - leading diagnotic chains in India market leadership in North India and wide presence across India. First diagnostic company to get listed on Indian stock exchange and one of the authorised chains for COVID-19 testing
You like to know more. We like that!
Please subscribe Model Portfolio Plan to get access of all premium model portfolio articles Only at Rs 7499/Year.